168 related articles for article (PubMed ID: 2952015)
1. Localization of S protein and its relationship to the membrane attack complex of complement in renal tissue.
Falk RJ; Podack E; Dalmasso AP; Jennette JC
Am J Pathol; 1987 Apr; 127(1):182-90. PubMed ID: 2952015
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of complement S protein (Vitronectin) in normal and diseased human kidneys: relationship to neoantigens of the C5b-9 terminal complex.
Bariety J; Hinglais N; Bhakdi S; Mandet C; Rouchon M; Kazatchkine MD
Clin Exp Immunol; 1989 Jan; 75(1):76-81. PubMed ID: 2467771
[TBL] [Abstract][Full Text] [Related]
3. [Vitronectin in children with renal disease--1. Immunofluorescence study of vitronectin and C5b-9 in childhood IgA nephropathy].
Takahashi T; Inaba S; Okada T
Nihon Jinzo Gakkai Shi; 1995 Apr; 37(4):213-23. PubMed ID: 7541480
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of the C5b-9 complex of complement in human kidneys.
Hinglais N; Kazatchkine MD; Bhakdi S; Appay MD; Mandet C; Grossetete J; Bariety J
Kidney Int; 1986 Sep; 30(3):399-410. PubMed ID: 3537447
[TBL] [Abstract][Full Text] [Related]
5. Localization of terminal complement components S-protein and SP-40,40 in renal biopsies.
Murphy BF; Davies DJ; Morrow W; d'Apice AJ
Pathology; 1989 Oct; 21(4):275-8. PubMed ID: 2483750
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of C3d fragment of complement and S-protein (vitronectin) in normal and diseased human kidneys: association with the C5b-9 complex and vitronectin receptor.
Okada M; Yoshioka K; Takemura T; Akano N; Aya N; Murakami K; Maki S
Virchows Arch A Pathol Anat Histopathol; 1993; 422(5):367-73. PubMed ID: 8322453
[TBL] [Abstract][Full Text] [Related]
7. Histologic localization of terminal complement complexes in renal diseases. An immunohistochemical study.
Ootaka T; Suzuki M; Sudo K; Sato H; Seino J; Saito T; Yoshinaga K
Am J Clin Pathol; 1989 Feb; 91(2):144-51. PubMed ID: 2644805
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of C9 polymerization within the SC5b-9 complex of complement by S-protein.
Podack ER; Preissner KT; Müller-Eberhard HJ
Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():89-96. PubMed ID: 6587746
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of the terminal C5b-9 complement complex in children with glomerular diseases.
Rus HG; Niculescu F; Nanulescu M; Cristea A; Florescu P
Clin Exp Immunol; 1986 Jul; 65(1):66-72. PubMed ID: 3539428
[TBL] [Abstract][Full Text] [Related]
10. Complement-mediated cellular injury.
Takano T; Elimam H; Cybulsky AV
Semin Nephrol; 2013 Nov; 33(6):586-601. PubMed ID: 24161043
[TBL] [Abstract][Full Text] [Related]
11. The pathogenetic significance of C5b-9 in IgA nephropathy.
Alexopoulos E; Papaghianni A; Papadimitriou M
Nephrol Dial Transplant; 1995; 10(7):1166-72. PubMed ID: 7478119
[TBL] [Abstract][Full Text] [Related]
12. Neoantigen of the polymerized ninth component of complement. Characterization of a monoclonal antibody and immunohistochemical localization in renal disease.
Falk RJ; Dalmasso AP; Kim Y; Tsai CH; Scheinman JI; Gewurz H; Michael AF
J Clin Invest; 1983 Aug; 72(2):560-73. PubMed ID: 6348093
[TBL] [Abstract][Full Text] [Related]
13. C5b-9 deposition in children with glomerular diseases.
Nanulescu M; Rus HG; Niculescu F; Cristea A; Florescu P
Med Interne; 1987; 25(2):99-104. PubMed ID: 3303285
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of the terminal C5b-9 complement complex in human aortic fibrous plaque.
Vlaicu R; Niculescu F; Rus HG; Cristea A
Atherosclerosis; 1985 Nov; 57(2-3):163-77. PubMed ID: 3910058
[TBL] [Abstract][Full Text] [Related]
15. Renal C3 synthesis in idiopathic membranous nephropathy: correlation to urinary C5b-9 excretion.
Montinaro V; Lopez A; Monno R; Cappiello V; Manno C; Gesualdo L; Schena FP
Kidney Int; 2000 Jan; 57(1):137-46. PubMed ID: 10620195
[TBL] [Abstract][Full Text] [Related]
16. Transcellular transport and membrane insertion of the C5b-9 membrane attack complex of complement by glomerular epithelial cells in experimental membranous nephropathy.
Kerjaschki D; Schulze M; Binder S; Kain R; Ojha PP; Susani M; Horvat R; Baker PJ; Couser WG
J Immunol; 1989 Jul; 143(2):546-52. PubMed ID: 2738403
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical studies of vitronectin, C5b-9, and vitronectin receptor in membranous nephropathy.
Ogawa T; Yorioka N; Yamakido M
Nephron; 1994; 68(1):87-96. PubMed ID: 7527506
[TBL] [Abstract][Full Text] [Related]
18. Deposition of the Membrane Attack Complex in Healthy and Diseased Human Kidneys.
Koopman JJE; van Essen MF; Rennke HG; de Vries APJ; van Kooten C
Front Immunol; 2020; 11():599974. PubMed ID: 33643288
[TBL] [Abstract][Full Text] [Related]
19. Urinary excretion of the C5b-9 membrane attack complex of complement is a marker of immune disease activity in autologous immune complex nephritis.
Pruchno CJ; Burns MM; Schulze M; Johnson RJ; Baker PJ; Alpers CE; Couser WG
Am J Pathol; 1991 Jan; 138(1):203-11. PubMed ID: 1987766
[TBL] [Abstract][Full Text] [Related]
20. The membrane attack complex in complement-mediated glomerular epithelial cell injury: formation and stability of C5b-9 and C5b-7 in rat membranous nephropathy.
Cybulsky AV; Quigg RJ; Salant DJ
J Immunol; 1986 Sep; 137(5):1511-6. PubMed ID: 3745914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
